Traduction de «paroxetine in patients with ischemic heart » (Français → Néerlandais) :

17. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS et al. Treatment of major depression with Nortriptyline and paroxetine in patients with ischemic heart disease.
17. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.

18. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr., Pollock BG et al. Comparison of paroxetine and Nortriptyline in depressed patients with ischemic heart disease.
18. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr., Pollock BG et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Furie KL, Kasner SE, Adams RJ et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
professionals from the American Heart Association/American Stroke Association.

Search Date February 2009. [http ...]
Aguilar MI, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: anti-thrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.

randomized trials.1 Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1). 1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1). 2, 3
treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1).1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1).2, 3

systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
16. Rouleau J, Roecker E, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

The Beta-Blocker Evaluation of Survival Trial Investigations: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
Naar The Beta-Blocker Evaluation of Survival Trial Investigations: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Discussion de: Zannad F, McMurray JJV, Krum H et al. Eplerenone in patients with systolic heart failure and mild symptoms.
Bespreking van: Zannad F, McMurray JJV, Krum H et al. Eplerenone in patients with systolic heart failure and mild symptoms.